Limbruno, U.; De Sensi, F.; Cresti, A.; Picchi, A.; Lena, F.; De Caterina, R.
Optimal Antithrombotic Treatment of Patients with Atrial Fibrillation Early after an Acute Coronary Syndrome—Triple Therapy, Dual Antithrombotic Therapy with an Anticoagulant… Or, Rather, Temporary Dual Antiplatelet Therapy? J. Clin. Med. 2020, 9, 2673.
https://doi.org/10.3390/jcm9082673
AMA Style
Limbruno U, De Sensi F, Cresti A, Picchi A, Lena F, De Caterina R.
Optimal Antithrombotic Treatment of Patients with Atrial Fibrillation Early after an Acute Coronary Syndrome—Triple Therapy, Dual Antithrombotic Therapy with an Anticoagulant… Or, Rather, Temporary Dual Antiplatelet Therapy? Journal of Clinical Medicine. 2020; 9(8):2673.
https://doi.org/10.3390/jcm9082673
Chicago/Turabian Style
Limbruno, Ugo, Francesco De Sensi, Alberto Cresti, Andrea Picchi, Fabio Lena, and Raffaele De Caterina.
2020. "Optimal Antithrombotic Treatment of Patients with Atrial Fibrillation Early after an Acute Coronary Syndrome—Triple Therapy, Dual Antithrombotic Therapy with an Anticoagulant… Or, Rather, Temporary Dual Antiplatelet Therapy?" Journal of Clinical Medicine 9, no. 8: 2673.
https://doi.org/10.3390/jcm9082673
APA Style
Limbruno, U., De Sensi, F., Cresti, A., Picchi, A., Lena, F., & De Caterina, R.
(2020). Optimal Antithrombotic Treatment of Patients with Atrial Fibrillation Early after an Acute Coronary Syndrome—Triple Therapy, Dual Antithrombotic Therapy with an Anticoagulant… Or, Rather, Temporary Dual Antiplatelet Therapy? Journal of Clinical Medicine, 9(8), 2673.
https://doi.org/10.3390/jcm9082673
